Found: 57
Select item for more details and to access through your institution.
Enhancing student understanding of rheumatic disease pathologies through augmented reality: findings from a multicentre trial.
- Published in:
- Rheumatology, 2024, v. 63, n. 7, p. 1949, doi. 10.1093/rheumatology/kead508
- By:
- Publication type:
- Article
Single German centre experience with patient journey and care-relevant needs in amyloidosis: The German <sub>A</sub>MY-NEED<sub>S</sub> research and care program.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0297182
- By:
- Publication type:
- Article
Tafamidis for cardiac transthyretin amyloidosis: application in a real-world setting in Germany.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Cardio-Hepatic Interaction in Cardiac Amyloidosis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1440, doi. 10.3390/jcm13051440
- By:
- Publication type:
- Article
AmyKoS—a German real-world prospective cohort study of patients with suspected and proven amyloidosis.
- Published in:
- Journal of Rare Diseases, 2024, v. 3, n. 1, p. 1, doi. 10.1007/s44162-024-00028-z
- By:
- Publication type:
- Article
Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma?: Exploring a large single center database using artificial intelligence.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5215, doi. 10.1007/s10238-023-01100-6
- By:
- Publication type:
- Article
An optimized cultivation method for future in vivo application of γδ T cells.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1185564
- By:
- Publication type:
- Article
Assessing Osteolytic Lesion Size on Sequential CT Scans Is a Reliable Study Endpoint for Bone Remineralization in Newly Diagnosed Multiple Myeloma.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 4008, doi. 10.3390/cancers15154008
- By:
- Publication type:
- Article
The influence of baseline characteristics, treatment and depression on health-related quality of life in patients with multiple myeloma: a prospective observational study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 12, p. 682, doi. 10.1159/000520364
- By:
- Publication type:
- Article
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 785, doi. 10.1016/j.clml.2021.06.005
- By:
- Publication type:
- Article
Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 529, doi. 10.1111/ejh.13690
- By:
- Publication type:
- Article
OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
- By:
- Publication type:
- Article
P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S150, doi. 10.1016/S2152-2650(21)02330-2
- By:
- Publication type:
- Article
Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based therapy (AGMT MM 1, phase II trial).
- Published in:
- EJHaem, 2021, v. 2, n. 1, p. 102, doi. 10.1002/jha2.130
- By:
- Publication type:
- Article
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 1, p. 205, doi. 10.1007/s00432-020-03323-6
- By:
- Publication type:
- Article
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Amyloidosis--the Diagnosis and Treatment of an Underdiagnosed Disease.
- Published in:
- Deutsches Ärzteblatt International, 2020, v. 117, n. 10, p. 159, doi. 10.3238/arztebl.2020.0159
- By:
- Publication type:
- Article
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 3, p. 749, doi. 10.1007/s00432-019-03101-z
- By:
- Publication type:
- Article
Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 455, doi. 10.3390/cancers12020455
- By:
- Publication type:
- Article
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 999, doi. 10.3390/jcm8070999
- By:
- Publication type:
- Article
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 3, p. 255, doi. 10.1111/ejh.13281
- By:
- Publication type:
- Article
Detection of cardiac amyloidosis with <sup>18</sup>F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1407, doi. 10.1007/s00259-019-04290-y
- By:
- Publication type:
- Article
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 999, doi. 10.3390/jcm8070999
- By:
- Publication type:
- Article
Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 3, p. 561, doi. 10.1007/s00432-018-2807-1
- By:
- Publication type:
- Article
Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making.
- Published in:
- MDM Policy & Practice, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1177/2381468318814253
- By:
- Publication type:
- Article
Dual-energy CT of the bone marrow in multiple myeloma: diagnostic accuracy for quantitative differentiation of infiltration patterns.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic value of [<sup>18</sup>F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 10, p. 1694, doi. 10.1007/s00259-018-3997-0
- By:
- Publication type:
- Article
[<sup>11</sup>C]Methionine emerges as a new biomarker for tracking active myeloma lesions.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 701, doi. 10.1111/bjh.14696
- By:
- Publication type:
- Article
The gross picture: intraindividual tumour heterogeneity in a patient with nonsecretory multiple myeloma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 6, p. 1097, doi. 10.1007/s00259-017-3656-x
- By:
- Publication type:
- Article
Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell Lymphoma.
- Published in:
- Acta Dermato-Venereologica, 2017, v. 97, n. 3, p. 379, doi. 10.2340/00015555-2564
- By:
- Publication type:
- Article
Ixazomib in Combination With Thalidomide and Dexamethasone as Treatment for Patients With Relapsed/Refractory Multiple Myeloma: An Ongoing Phase II Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e75, doi. 10.1016/j.clml.2017.03.136
- By:
- Publication type:
- Article
The Diagnosis and Treatment of Multiple Myeloma.
- Published in:
- Deutsches Ärzteblatt International, 2016, v. 113, n. 27/28, p. 470, doi. 10.3238/arztebl.2016.0470
- By:
- Publication type:
- Article
'Real-life' experience of preapproval carfilzomib-based therapy in myeloma - analysis of cardiac toxicity and predisposing factors.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 1, p. 25, doi. 10.1111/ejh.12677
- By:
- Publication type:
- Article
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with <sup>177</sup>Lu- and <sup>90</sup>Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 248, doi. 10.2967/jnumed.115.167361
- By:
- Publication type:
- Article
Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 1, p. 57, doi. 10.1111/bjh.13256
- By:
- Publication type:
- Article
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 4, p. 477, doi. 10.15252/emmm.201404698
- By:
- Publication type:
- Article
Biodistribution and Radiation Dosimetry for the Chemokine Receptor CXCR4-Targeting Probe <sup>68</sup>Ga-Pentixafor.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 3, p. 410, doi. 10.2967/jnumed.114.151647
- By:
- Publication type:
- Article
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M<sup>3</sup>P) in -17p high risk disease.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 4, p. 507, doi. 10.1111/bjh.13171
- By:
- Publication type:
- Article
Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature.
- Published in:
- Case Reports in Oncology, 2015, v. 8, n. 1, p. 189, doi. 10.1159/000381983
- By:
- Publication type:
- Article
Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0115910
- By:
- Publication type:
- Article
Lethal autoimmune hemagglutination due to an immunoglobulin A autoagglutinin with Band 3 specificity.
- Published in:
- Transfusion, 2014, v. 54, n. 8, p. 1988, doi. 10.1111/trf.12638
- By:
- Publication type:
- Article
The lymphoma-like polychemotherapy regimen 'Dexa-BEAM' in advanced and extramedullary multiple myeloma.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 7, p. 1207, doi. 10.1007/s00277-014-2023-2
- By:
- Publication type:
- Article
Sporadic late onset nemaline myopathy and immunoglobulin deposition disease.
- Published in:
- Muscle & Nerve, 2013, v. 48, n. 6, p. 983, doi. 10.1002/mus.23954
- By:
- Publication type:
- Article
Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0084840
- By:
- Publication type:
- Article
Impact of Regional Left Ventricular Function on Outcome for Patients with AL Amyloidosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0056923
- By:
- Publication type:
- Article